Role of nitric oxide in the nicotine-induced pituitary-adrenocortical response

Journal of Physiology and Pharmacology

Volumn 55, Issue 2, 2004, Pages 443-455

  Gadek Michalska A ^a   Bugajski, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

HPA activity; Nicotine; Nitric oxide; Nitric oxide synthase; Prostaglandins in NOS induced HPA activity

Indexed keywords

7 NITROINDAZOLE; CORTICOSTERONE; CORTICOTROPIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANETHIDINE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; NICOTINE; NICOTINIC RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; PROSTAGLANDIN RELEASE; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ARGININE; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; NICOTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; PITUITARY-ADRENAL SYSTEM; RATS;

EID: 3142585072     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dani JA. Nicotine mechanisms in Alzheimer's disease. Overview of nicotinic receptors and their roles in the central nervous system. Biol Psychiatry 2001; 49: 166-174.
2. Galzi J-L, Changeux J-P. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology 1995; 34: 563-582.
3. Matta SG, Beyer HS, McAllen KM, Sharp BM. Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Ther 1987; 243: 217-226.
4. Okuda H, Shioda S, Nakai Y, Nakayama H, Okamoto M, Nakashima T. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neurosci Lett 1993; 161: 183-186.
5. Stern JE. Nitric oxide and homeostatic control: an intracellular signalling molecule contributing to autonomic and neuroendocrine integration? Progress in Biophysics and Molecular Biology 2004; 84: 197-215.
6. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog Neurobiol 2001; 64: 365-391.
7. Heinzen EL, Pollack GM. Pharmacokinetics and pharmacodynamics of L-arginine in rats: a model of stimulated neuronal nitric oxide synthesis. Brain Res 2003; 989: 76-75.
8. Kiss JP. Role of nitric oxide in the regulation of monoaminergic neurotransmission. Brain Res Bull 2000; 52: 459-466.
9. Wegener G, Volke V, Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br J Pharmacol 2000; 130: 575-580.
10. Bugajski J, Borycz J, Ga̧dek-Michalska A, Głód R, Bugajski AJ. Mediation by nitric oxide of the carbachol-induced corticosterone secretion in rats. J Physiol Pharmacol 1997; 2: 277-284.
11. Bugajski AJ, Koprowska B, Thor P, Głód R, Bugajski J. Involvement of nitric oxide in central histaminergic stimulation of the hypothalamic-pituitary-adrenal axis. J Physiol Pharmacol 2000; 51: 907-915.
12. Bugajski J, Ga̧dek-Michalska A, Głód R, Borycz J, Bugajski AJ. Blockade of nitric oxide formation impairs adrenergic-induced ACTH and corticosterone secretion. J Physiol Pharmacol 1999; 50: 327-335.
13. Vidwans AS, Uliasz TF, Hewett JA, Hewett SJ. Differential modulation of prostaglandin H synthase-2 by nitric oxide-related species in intact cells. Biochemistry 2001; 40: 11533-11542.
14. Ga̧dek-Michalska A, Bugajski J, Bugajski AJ, Głód R. Effect of adrenergic antagonists and cyclooxygenase inhibitors on the nicotine-induced hypothalamic-pituitary-adrenocortical activity. J Physiol Pharmacol 2002; 53: 275-287.
15. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Effect of constitutive- and inducible-cyclooxygenase in the carbachol-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2002; 53: 453-462.
16. Prevot V, Bouret S, Stefano GB, Beauvillain JC. Median eminence nitric oxide signaling. Brain Res Rev 2000; 34: 27-41.
17. Lafuente A, Gonzalez-Carracedo A, Romero A, Cano P, Esquifino AI. Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents. Life Sci 2004; 74: 1681-1690.
18. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson RJ, Currie MG. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125.
19. Nilsson BO. Biological effects of aminoguanidine: An update. Inflamm Res 1999; 48: 509-515.
20. Corbett JA, McDaniel ML. Selective inhibition of inducible nitric oxide synthase by aminoguanidine. In Methods in Enzymology, vol 268. Academic Press. Inc, 1996.
21. Hasan K, Heesen B-J, Corbett JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BHR, Williamson JR, Tilton RG. Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 1993; 249: 101-106.
22. Bugajski J, Ga̧dek-Michalska A, Bugajski AJ. Involvement of prostaglandins in the nicotine-induced pituitary-adrenocortical response during social stress. J Physiol Pharmacol 2002; 53: 847-857.
23. Goodwin DC, Landino LM, Marnett LJ. Reaction of prostaglandin endoperoxide synthase with nitric oxide and peroxynitrite. Drug Metabol Rev 1999; 31: 273-294.
24. Marnett LJ, Wright TL, Crews BC, Tannenbaum SR, Morrow JD. Regulation of prostaglandin biosynthesis by nitric oxide is revealed by targeted deletion of inducible nitric-oxide synthase. J Biol Chem 2000; 275: 13427-13430.
25. River C. Blockade of nitric oxide formation augments adrenocorticotropin released by blood-borne interleukin-1 beta: role of vasopressin, prostaglandins, and alpha 1-adrenergic receptors. Endocrinology 1995; 136: 3597-3603.